Skip to content

SRZN

Surrozen, Inc.

NASDAQ · USHealthcareBiotechnology
$22.16+0.91%

Price as of Jul 20, 2026

SRZN capital

Surrozen, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
-0.02x
Net debt / equity
0.36x
Debt / assets
0.06x
Debt / EBITDA
-0.02x
Net debt / EBITDA
0.29x

Liquidity & coverage

Current ratio
11.91x
Quick ratio
11.91x
Cash ratio
11.18x
Interest coverage
EBITDA / interest
Working capital
$104.4M

Cash & dividend

FCF / debt
-4.97x
Cash flow / debt
-4.94x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.